top of page



This is a Phase 3, international, randomised, investigator-blind, multicentre, vehicle and
comparator controlled, parallel-group, 3-arm trial for subjects with mild-to-moderate psoriasis
vulgaris. Subjects will apply trial medication to affected non-scalp areas of the body (trunk and/or limbs) topically once daily for 8 weeks.The maximum trial duration for each subject will be approximately 14 weeks and includes a screening period of up to 4 weeks (if washout of prohibited medications is required), an 8-week treatment period, and a follow-up period of 2 weeks. 

Do you Qualify?

​These questions require a yes answer to qualify.​

  • Are you at least 18 years of age?

  • Have you been clinically diagnosed for at least 6 months?

  • Does the effected area cover between 2% and 30% of your body?

​These questions require a no answer to qualify.​

  • Are you currently pregnant, plan to become pregnant or breastfeeding?

  • Have you taken any biologic therapy for psoriasis treatment?

  • Currently suffering from any major illnesses that may require extended hospitalization?

  • Do you suffer from any other inflammatory skin diseases?

If you think you may be eligible for this trial, please give us a call to schedule an appointment or click button below to email a request.

bottom of page